OrganiGram Holdings Inc.

TSX:OGI.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.96 -1.43%

-$0.02 today

Market cap
$135.37M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $1.37High $3.09

Volume 0.54M

Average 0.19M

OGI.TO Other Financing Activities

Financing cash flows not reported separately.

OrganiGram Holdings Inc.TSX: OGI.TO

Other Financing Activities · Q2 FY2026 · quarter ended Mar 2026

Other financing activities turns negative

Q2 FY2026 other financing activities was -CA$390K, compared with CA$41.18M a year earlier. Trailing-twelve-month other financing activities was -CA$1.93M.

Context

  • Other financing activities amounted to 0.7% of revenue in FY2025, up 0.7 pp from a year earlier.
  • Other financing activities increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly other financing activities holds near -CA$390K or moves back toward the trailing-twelve-month quarterly average of -CA$482.5K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$390K-11.6% QoQ
Last fiscal yearSep 2025
-CA$1.79M-29900.0% YoY
LTMMar 2026
-CA$1.93M-104.7% YoY
Other Financing Activities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.9%——
1 year-29900.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Financing Activities history

CAD · from the cash flow

Latest · FY2025
(1.79M) CAD
Year-over-year change
-29900.0%

Other Financing Activities vs competitors

How OGI.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so other financing activities is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -104.7% is the 9th highest of 10, against a peer median of +41.0%.
  • Other financing activities amounts to 0.7% of revenue for OGI.TO, versus a peer median of 2.1%.
OGI.TO Competitors
Other Financing Activities for OGI.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DR.TOMedical Facilities CorporationLTM Mar 2026$32.48M USD+16.5%+11.6%10.6%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$29.63M CAD+85.7%-9.2%9.5%
TSND.TOTerrAscend Corp.LTM Mar 2026$4.12M USD-49.2%-43.0%1.6%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$2.07M CAD+223.6%—1.3%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026CA$1.93M CAD-104.7%—0.7%
HLS.TOHLS Therapeutics Inc.LTM Mar 2026$1.75M USD+41.0%+11.1%3.1%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$1.3M USD+110.7%—2.5%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$154K CAD-175.9%-88.3%0.0%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$110.12K USD-71.7%—0.2%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026$82.21K USD+1844.9%——
Peer median (excluding OGI.TO) —+41.0%-9.2%2.1%

Competitors are the stored peer set for OGI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(24.76M)
Depreciation & Amortization31.03M24.91M24.17M12.08M17.98M
Deferred Income Tax42.21M(88K)(3.62M)0(13.77M)
Stock-Based Compensation3.9M5.13M5.29M7.18M4.22M
Change in Working Capital24.2M(22.88M)12.51M14.96M(2.12M)
Accounts Receivables(6.01M)(24.02M)12.51M(12.06M)(15.29M)
Inventory28.68M(12.22M)000
Accounts Payables2.06M12.15M000
Other Working Capital(542K)1.21M(5.52M)27.02M13.16M
Other Non-Cash Items776K(29M)155.33M15.09M12.47M
Operating Cash Flow(28.59M)(36.21M)(35.8M)3.87M(7.59M)
Capital Expenditures(12.33M)(48.78M)(26.9M)(5.34M)(17.05M)
Acquisitions (Net)(2.54M)(11.06M)1.03M257K(65.62M)
Purchases of Investments(120.02M)(15M)(10M)(29.24M)(1.01M)
Sales of Investments50.85M114.59M49.4M3.52M2.5M
Other Investing Activities(31.08M)4.29M(8.65M)(7.97M)(1.52M)
Investing Cash Flow(115.11M)44.03M1.36M(38.77M)(82.67M)
Debt Repayment(116.4M)(1.01M)(87K)(786K)(60K)
Common Stock Issued284.88M6.34M20K108.56M41.18M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities5.99M6.34M(750K)6K(1.79M)
Financing Cash Flow174.46M5.33M(817K)107.78M39.33M
Effect of Forex Changes0000313K
Net Change in Cash30.77M13.15M(34.65M)72.88M(49.01M)
Free Cash Flow(40.92M)(84.99M)(62.7M)(1.47M)(24.64M)

OrganiGram Holdings Inc.

TSX:OGI.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.